Barker, Edward D
,
Ing, Alex
Biondo, Francesca http://orcid.org/0000-0001-9952-0249
Jia, Tianye http://orcid.org/0000-0001-5399-2953
Pingault, Jean-Baptiste
Du Rietz, Ebba
Zhang, Yuning
Ruggeri, Barbara
Banaschewski, Tobias
Hohmann, Sarah
Bokde, Arun L. W
Bromberg, Uli
Büchel, Christian
Quinlan, Erin Burke http://orcid.org/0000-0003-2927-1632
Sounga-Barke, Edmund
Bowling, April B.
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta
Frouin, Vincent http://orcid.org/0000-0001-9360-6623
Garavan, Hugh
Asherson, Philip
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère http://orcid.org/0000-0002-0452-2450
Nees, Frauke
Papadopoulos-Orfanos, Dimitri http://orcid.org/0000-0002-1242-8990
Poustka, Luise
Smolka, Michael N http://orcid.org/0000-0001-5398-5569
Vetter, Nora C.
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert http://orcid.org/0000-0002-2790-7281
Schumann, Gunter
Article History
Received: 22 January 2019
Revised: 29 April 2019
Accepted: 3 May 2019
First Online: 21 June 2019
Compliance with ethical standards
:
: TB has served as an adviser or consultant for Actelion, Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Hexal Pharma, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; he has been involved in clinical trials conducted by Eli Lilly, Novartis, Shire, and Vifor Pharma; and he has received royalties from CIP Medien, Hogrefe, Kohlhammer, and Oxford University Press. EDB has received grant support, including Ph.D. support, from General Electric Healthcare; he has served as a consultant for IXICO, and he has received an honorarium for teaching in a scanner programming course run by General Electric Healthcare. ALWB has received funding from the Science Foundation Ireland Stokes Programme (07/SK/B1214a). PG has received a research grant from Lyndra and an honorarium paid to her employer from GlaxoSmithKline. LP has received conference attendance support or speaking fees from Medice, Novartis, and Shire. HW has received a speaking honorarium from Servier. Dr. Buitelaar has served as a consultant, advisory board member, or speaker for Eli Lilly, Janssen-Cilag BV, Novartis, Lundbeck, Roche, Servier, and Shire. Dr. Glennon has served as a consultant for Boehringer Ingelheim. The remaining authors declare that they have no conflict of interest.